The findings of this study highlighted a robust correlation between distinctly decreased CTR1 expression levels and reduced intracellular Pt concentrations, attenuated DNA platination and an overall decreased platinum sensitivity in the resistant cancer cell sublines (Zisowsky et al., 2007). The gene discussed is SLC31A1; the disease is cancer.